Longeveron hires financial advisor to explore strategic options

Go back to Longeveron hires financial advisor to explore strategic options

Longeveron Announces Engagement of Lucid Capital Markets

October 28, 2026 9:15 AM EDT

MIAMI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (the Company) (NASDAQ: LGVN), today announced that the Company has retained Lucid Capital Markets, LLC as the Companys financial advisor to explore potential strategic opportunities, including a potential business combination.

About Longeveron Inc.

Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Companys lead investigational product... More